ANIK Anika Therapeutics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Anika Therapeutics, Inc. (ANIK) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 3, 2026, a 10-Q quarterly report filed on April 30, 2026, an 8-K current report filed on July 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Anika Therapeutics, Inc. (ANIK) (SEC CIK 898437), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Anika Therapeutics, Inc.
Ask AI about ANIK filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting ANIK positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on ANIK.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Anika Therapeutics, Inc. (ANIK) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 29, 2026 | - | - | - |
8-K | Jul 14, 2026 | - | - | - |
8-K | Jun 23, 2026 | - | - | - |
10-Q | Apr 30, 2026 | Mar 31, 2026 | - | |
8-K | Apr 29, 2026 | - | - | - |
10-K | Mar 3, 2026 | Dec 31, 2025 | - | |
8-K | Feb 26, 2026 | - | Analysis | - |
8-K | Jan 8, 2026 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Jul 30, 2025 | Jun 30, 2025 | - | |
10-Q | May 9, 2025 | Mar 31, 2025 | - | |
10-K | Mar 17, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 4, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
10-Q | May 8, 2024 | Mar 31, 2024 | - | |
10-K | Mar 15, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 3, 2023 | Sep 30, 2023 | - | |
SC 13D | Aug 17, 2023 | - | - | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | - | |
10-Q | May 9, 2023 | Mar 31, 2023 | - | |
10-K | Mar 16, 2023 | Dec 31, 2022 | - | |
SC 13G | Jan 20, 2023 | - | - | |
10-Q | Nov 9, 2022 | Sep 30, 2022 | - | |
SC 13G | Oct 7, 2022 | - | - | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate ANIK share value held by 13F filers tracked by SignalX, by quarter.
- AQR Capital Management+203.0K (+293%)
- Morgan Stanley+99.8K (+13%)
- Goldman Sachs Group+53.0K (+32%)
- Citadel Advisors LLC+21.0K (+45%)
- FMR LLC (Fidelity)+14.9K (+45%)
- D.E. Shaw & Co68.2K (-23%)
- BlackRock59.6K (-4%)
- Dimensional Fund Advisors35.5K (-7%)
- Citigroup15.6K (-96%)
- Renaissance Technologies LLC13.5K (-3%)
- Vanguard Group Inc−779.2K
- JPMorgan Chase & Co−33.3K
- Millennium Management−26.2K
- Invesco Ltd−25.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 155 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest ANIK SEC filings in 2026?
Anika Therapeutics, Inc. (ANIK) has filed a 10-K annual report on March 3, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on July 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ANIK file its most recent 10-K annual report?
Anika Therapeutics, Inc. (ANIK) filed its most recent 10-K annual report on March 3, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ANIK 10-Q quarterly reports?
Anika Therapeutics, Inc. (ANIK)'s most recent 10-Q quarterly report was filed on April 30, 2026. SignalX displays every ANIK 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ANIK filed recently?
Anika Therapeutics, Inc. (ANIK)'s most recent 8-K was filed on July 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ANIK insider trading activity (Form 4)?
SignalX aggregates every ANIK Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ANIK file with the SEC?
Anika Therapeutics, Inc. (ANIK) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ANIK filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Anika Therapeutics, Inc. (ANIK).
What is ANIK's SEC CIK number?
Anika Therapeutics, Inc. (ANIK)'s SEC CIK (Central Index Key) number is 898437. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 898437 to look up all ANIK filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Anika Therapeutics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 126+ filings.